ALDR
Alder Biopharmaceuticals, Inc.
ALDR
ALDR
Delisted
ALDR was delisted on the 21st of October, 2019.
140 hedge funds and large institutions have $756M invested in Alder Biopharmaceuticals, Inc. in 2017 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 58 increasing their positions, 32 reducing their positions, and 19 closing their positions.
Holders
140
Holders Change
+8
Holders Change %
+6.06%
% of All Funds
3.18%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.07%
New
27
Increased
58
Reduced
32
Closed
19
Calls
$799K
Puts
$1.17M
Net Calls
-$367K
Net Calls Change
+$165K
Top Buyers
| 1 |
PAI
1
Palo Alto Investors
Palo Alto,
California
|
$21.1M |
| 2 |
2
Balyasny Asset Management
Chicago,
Illinois
|
$6.95M |
| 3 |
3
Citadel Advisors
Miami,
Florida
|
$27.3M |
| 4 |
4
Morgan Stanley
New York
|
$13.2M |
| 5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$61.4M |
